David A Katz

4PUBLICATIONS
3CO-AUTHORS
Biologically active moleculesArtificial life and complex adaptive systemsCheminformatics and quantitative structure-activity relationshipsPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Nov 15, 2025
Human Adipose Tissue 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibition Without Tachyphylaxis by Clofutriben, a Pseudo-Irreversible Enzyme Inhibitor.

Guohua An, Julio A Gutierrez, Cele Abad-Zapatero

|Dec 23, 2023
Dexamethasone Suppression Testing in a Contemporary Cohort with Adrenal Incidentalomas in Two U.S. Integrated Healthcare Systems.

Mackenzie Crawford, Bennett McDonald, Wansu Chen

|Dec 08, 2022
Importance of Target-Mediated Drug Disposition (TMDD) of Small-Molecule Compounds and Its Impact on Drug Development-Example of the Class Effect of HSD-1 Inhibitors.

Guohua An, David A Katz

|Jun 10, 2021
A Target-Mediated Drug Disposition Model to Explain Nonlinear Pharmacokinetics of the 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitor SPI-62 in Healthy Adults.

Nan Wu, David A Katz, Guohua An

Pageof 1

Frequent Collaborators

3 joint publications

Guohua An

1 joint publications

Mackenzie Crawford

1 joint publications

Cele Abad-Zapatero